BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 16809305)

  • 1. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM; Ezelle H; Shah S; Barber GN
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
    Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H
    Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.
    Ezelle HJ; Markovic D; Barber GN
    J Virol; 2002 Dec; 76(23):12325-34. PubMed ID: 12414973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
    Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core-E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus.
    Alvarez-Lajonchere L; Amador-Cañizares Y; Frías R; Milian Y; Musacchio A; Guerra I; Acosta-Rivero N; Martínez G; Castro J; Puentes P; Cosme K; Dueñas-Carrera S
    Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):97-105. PubMed ID: 18215116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.
    Braxton CL; Puckett SH; Mizel SB; Lyles DS
    J Virol; 2010 Apr; 84(7):3552-61. PubMed ID: 20089648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.
    Kahn JS; Roberts A; Weibel C; Buonocore L; Rose JK
    J Virol; 2001 Nov; 75(22):11079-87. PubMed ID: 11602747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.
    Lagging LM; Meyer K; Owens RJ; Ray R
    J Virol; 1998 May; 72(5):3539-46. PubMed ID: 9557633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector.
    Publicover J; Ramsburg E; Rose JK
    J Virol; 2005 Nov; 79(21):13231-8. PubMed ID: 16227246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of pseudotype VSV possessing HCV envelope proteins.
    Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
    Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses.
    Seong YR; Choi S; Lim JS; Lee CH; Lee CK; Im DS
    Vaccine; 2001 Apr; 19(20-22):2955-64. PubMed ID: 11282207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.
    Cobleigh MA; Bradfield C; Liu Y; Mehta A; Robek MD
    J Virol; 2012 Apr; 86(8):4253-61. PubMed ID: 22345454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
    Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer.
    Meyer K; Beyene A; Bowlin TL; Basu A; Ray R
    J Virol; 2004 Dec; 78(23):12838-47. PubMed ID: 15542636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
    Siler CA; McGettigan JP; Dietzschold B; Herrine SK; Dubuisson J; Pomerantz RJ; Schnell MJ
    Virology; 2002 Jan; 292(1):24-34. PubMed ID: 11878905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
    Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice.
    Lee BH; Yoshimatsu K; Araki K; Okumura M; Nakamura I; Arikawa J
    Vaccine; 2006 Apr; 24(15):2928-34. PubMed ID: 16426712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an infectious surrogate hepatitis C virus based on a recombinant vesicular stomatitis virus expressing hepatitis C virus envelope glycoproteins and green fluorescent protein.
    Okuma K; Fukagawa K; Tateyama S; Kohma T; Mochida K; Hiyoshi M; Takahama Y; Hamaguchi Y; Hirose K; Buonocore L; Rose JK; Mizuochi T; Hamaguchi I
    Jpn J Infect Dis; 2015; 68(3):203-8. PubMed ID: 25672345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.